Breast carcinomas are classified into four major molecular subtypes, largely defined by the expression of hormonal receptors (estrogen and progesterone) and HER2 receptor: luminal A, luminal B, HER2 positive, and triple negative or basal like. Here, ERBB2 is linked to breast carcinoma.